Your browser doesn't support javascript.
loading
The Dilemma of HSV-1 Oncolytic Virus Delivery: The Method Choice and Hurdles.
Tang, Guijin; Wang, Dawei; Zhao, Xiangqian; Feng, Zhihua; Chen, Qi; Shen, Yangkun.
Afiliação
  • Tang G; Fujian Key Laboratory of Innate Immune Biology, Biomedical Research Center of South China, Qishan Campus, Fujian Normal University, College Town, Fuzhou 350117, China.
  • Wang D; Fujian Key Laboratory of Innate Immune Biology, Biomedical Research Center of South China, Qishan Campus, Fujian Normal University, College Town, Fuzhou 350117, China.
  • Zhao X; Fujian Key Laboratory of Innate Immune Biology, Biomedical Research Center of South China, Qishan Campus, Fujian Normal University, College Town, Fuzhou 350117, China.
  • Feng Z; Fujian Key Laboratory of Innate Immune Biology, Biomedical Research Center of South China, Qishan Campus, Fujian Normal University, College Town, Fuzhou 350117, China.
  • Chen Q; Fujian Key Laboratory of Innate Immune Biology, Biomedical Research Center of South China, Qishan Campus, Fujian Normal University, College Town, Fuzhou 350117, China.
  • Shen Y; Fujian Key Laboratory of Innate Immune Biology, Biomedical Research Center of South China, Qishan Campus, Fujian Normal University, College Town, Fuzhou 350117, China.
Int J Mol Sci ; 24(4)2023 Feb 12.
Article em En | MEDLINE | ID: mdl-36835091
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Herpesvirus Humano 1 / Vírus Oncolíticos / Terapia Viral Oncolítica / Neoplasias Limite: Humans Idioma: En Revista: Int J Mol Sci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Herpesvirus Humano 1 / Vírus Oncolíticos / Terapia Viral Oncolítica / Neoplasias Limite: Humans Idioma: En Revista: Int J Mol Sci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China